Chloroquine in glioblastoma—New horizons for an old drug

Interesting clinical data have emerged about clinical experience with chloroquine as adjuvant therapy for patients with glioblastoma multiforme (GBM). Chloroquine has the potential of opening new frontiers in the treatment of glial neoplasms and should be tested in large clinical trials.